In This Section      
 

Search Results

Title:
Biomarker Detection in Men with Relapsed Prostate Cancer
Protocol Number:
J1850
Phase:
NULL
Physician:
Mario Eisenberger
Sites:
Johns Hopkins Kimmel Cancer Center in Baltimore
Purpose:
This study is being done to collect and bank biospecimens and clinical data from men with prostate cancer. This bank of samples may be used now and in the future to conduct research to accomplish the goal of creating better cancer therapies and develop new biomarkers.
Eligibility:
Men must have clinical or biochemical evidence of active prostate cancer (all disease states).
Treatment:
Blood Sample will be collected before starting new therapy, every 3 months or at clinically-relevant time points (time of disease worsening). Urine sample will be collected at the same time points as the blood sample collection.
Population:
Adult
Last Update
03/05/2019 05:03 AM